FY2025 · ended Dec 31, 2025 · Revenue $0 · Filed Feb 11, 2026
Acro Biomedical Co., Ltd. (ACBM) files with the SEC under industry code 7900, Services-Amusement & Recreation Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $0 and a net loss of $101,146.
Revenue (TTM)
$0
Net income (TTM)
$-140,413
-200.3% vs year-ago TTM
Operating cash flow (TTM)
$-140,112
-5.1% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.00
-200.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
60.04M
+0.0% vs prior year
Net cash
$4,098
FY 2025
Operating margin
-2410.0%
FY 2022
Company profile
- Industry
- Services-Amusement & Recreation Services (SIC 7900)
- Listed as
- ACBM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fishers, IN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1622996
- Former names
- KILLER WAVES HAWAII, INC (until Jan 30, 2017)
Other Services-Amusement & Recreation Services companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $658,500 | $1.2M |
| Operating income | -$154,024 | -$37,958 | -$8.8M | -$15.9M | -$7.7M |
| Net income | -$101,146 | -$42,297 | -$8.8M | -$15.9M | -$7.7M |
| Diluted EPS | $0.00 | $0.00 | -$0.15 | — | — |
| Operating cash flow | -$196,302 | -$36,692 | -$15,446 | -$147,481 | $299,335 |
| Total assets | $14,098 | $31,974 | $58,459 | $687,486 | $761,077 |
| Total liabilities | — | $326,946 | $315,473 | $201,116 | $117,370 |
| Stockholders' equity | -$386,964 | -$294,972 | -$257,014 | $486,370 | $643,707 |
| Cash and investments | $4,098 | $476 | $376 | $5,852 | — |
| Total debt | $0 | $26,898 | $52,233 | $25,719 | $50,432 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Sep 2, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Jan 8, 2026 | Jan 4, 2026 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
All 91 Acro Biomedical Co., Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.